N. BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
(RTTNews) - Lantheus Holdings, Inc. (LNTH) announced the FDA has approved the supplemental new drug application for DEFINITY as an ultrasound enhancing agent for use in pediatric patients with ...
NORTH BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results